Search
SHAREHOLDER ACTION: Dalton Gooding and William Dolphin are the two casualties from Avita Medical's AGM. Photo: Attila Csaszar

Dolphin steps down as Avita CEO

William Dolphin has agreed to step down as chief executive of biotech company Avita Medical, and Dalton Gooding has resigned after announcing his intention to do so at the company's annual general meeting in November.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLedge Finance

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/12/18

1 year TSR5 year TSR
110thAvita Medical29%-7%
487thHolista Colltech-33%-10%
506thRefresh Group-37%9%
579thWestStar Industrial-47%-56%
732ndAdvanced Braking Technology-67%-34%
716 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

10/01/19
$0 Other
10/01/19
$0 Other
10/01/19
$15k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

86th↑Avita Medical$11.3m
89th↑WestStar Industrial$9.1m
90th↓Refresh Group$8.8m
92nd↑Holista Colltech$8.0m
93rd↓Advanced Braking Technology$7.9m
237 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer